Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by IvankaThePariahon Feb 10, 2021 12:56am
121 Views
Post# 32521780

RE:For the longs

RE:For the longs

Would just chime in here that "the second half of fiscal 2022" is not as far off as it sounds.  For those, like me, who are fiscally challenged - and do correct me if I'm wrong Westie - today's ER was for 3rd quarter 2021. Which means Canopy's ER for "2nd half of fiscal 2022", as you have said, falls at the end of this year, 2021.  Canopy will report positive EBITDA in EARLY 2022, if not before.

2020 & 2021 have & continue to combine the elements of A Perfect Storm of societal & political opportunity for our sector in general and our company in particular.  It's no coincidence that every major LP rose today, and continued to rise after hours, on the Canopy ER and the words of its CEO (among other not insignificant developments of course).  The earth's beginning to shake and the doors on the bullet train are closing.  This is 2017-18 all over again, but on steroids.  Happily, having lived through it - survived it - the first time, I am content to sit back with a big bowl of popcorn and watch the show - you know, that show where the shorts drag themselves, legless and ripped to shreds, across the bloodied sands of the Coliseum and beg the emperor for mercy.  Nahhh. Not this time.


WestCoast78 wrote: looks like sector squeeze is going on.  We will have many more big days ahead.  More importantly, DK just conservatively provided guidance to profitability and eventually FCF.  These times did NOT have usa thc factored in.   The way now see it, Chuck will spend a few months dialing in the new legislation.  Id guess by summer or sooner that goes into law.  Two months after we enter usa thc, which will probably be early Fall.  The second half of fiscal 2022 we go EBITDA postive.  Same time next year.   I for one, am sitting back with pop corn, and enjoying the roast whilst enjoying my favourite canopy products.

Arpil 2019 - Oct 2020 was disgusting.

November 2020 - November 2025 will be one for the record books.

Enjoy, all longs, make the most of it.  USA THC only happens once, then EU THC also only once.

 

<< Previous
Bullboard Posts
Next >>